NEW YORK (GenomeWeb News) – Nanosphere reported after the close of the market Wednesday that its full-year revenues more than doubled and it trimmed its annual loss.

The firm also announced a management shakeup, which includes the naming of a new CEO and the replacement of several board members. Wall Street reacted negatively to the changes and a revenue forecast below expectations, sending the firm's shares tumbling 30 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.